# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY

A. 510(k) Number: K152961   
B. Purpose for Submission: Clearance of a new device   
C. Measurand: D-Dimer   
D. Type of Test: Quantitative   
E. Applicant: Maine Standards Company LLC   
F. Proprietary and Established Na VALIDATE® D-Dimer Calibratio

# G. Regulatory Information:

1. Regulation section: 21 CFR 864.5425, Multipurpose system for in vitro coagulation studies

2. Classification: Class II

3. Product code: GGN, Plasma, coagulation control

4. Panel: 81 (Hematology)

# H. Intended Use:

1. Intended use(s):

VALIDATE® D-Dimer Calibration Verification/Linearity Test Kit solutions are an assayed quality control materials intended for in vitro diagnostic use in the quantitative determination of linearity, calibration verification and verification of reportable range for the following analyte: D-Dimer in a clinical laboratory setting by laboratory personnel. The product is intended for use with quantitative assays on the indicated analyzers specified in the labeling.

2. Indication(s) for use: Same as intended use

3. Special conditions for use statement(s): For prescription use only

4. Special instrument requirements: Instrumentation Laboratory (IL) ACL TOP Family and HemosIL® D-Dimer HS assay

# I. Device Description:

The VALIDATE D-Dimer Calibration Verification/Linearity Test Kit is a liquid quality control material designed to confirm the proper calibration of the measuring range of HemosIL D-Dimer HS assay on IL ACL TOP Family. The kit includes five levels of DDimer analyte in a human plasma base matrix.

# J. Substantial Equivalence Information:

1. Predicate device name(s): Aalto Scientific Ltd., Audit Micro CV D-Dimer Linearity Set

2. Predicate 510(k) number(s): K100716

3. Comparison with predicate:

<table><tr><td rowspan=1 colspan=3>Similarities</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>DeviceVALIDATE D-Dimer CalibrationVerification/Linearity Test Kit</td><td rowspan=1 colspan=1>PredicateAudit MicroCV D-DimerLinearity Set</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>VALIDATE® D-DimerCalibration Verification/LinearityTest Kit solutions are an assayedquality control materials intendedfor in vitro diagnostic use in thequantitative determination oflinearity, calibration verificationand verification of reportablerange for the following analyte: D-dimer in a clinical laboratorysettings by laboratory personnel.The product is intended for usewith quantitative assays on theindicated analyzers specified in thelabeling.</td><td rowspan=1 colspan=1>The AuditTM MicroCVTM D-Dimer Linearity Set is aquantitative, assayed qualitycontrol material consisting of fivelevels of D-dimer analyte. Thefive D-dimer levels demonstrate alinear analyte. The AuditTMMicroCV D-Dimer LinearitySet is intended to use with theBiomerieux miniVIDASanalyzer and VIDAS D-dimerassay to verify the calibration ofthe measuring range.For In Vitro Diagnostic Use Only.</td></tr><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>D-dimer</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Human based plasma</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Number ofLevels per kit</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>Same</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate</td></tr><tr><td rowspan=1 colspan=1>Matrix State</td><td rowspan=1 colspan=1>Liquid</td><td rowspan=1 colspan=1>Lyophilized</td></tr><tr><td rowspan=1 colspan=1>Closed VialStability</td><td rowspan=1 colspan=1>-10 to &quot;25 °C for 9 months</td><td rowspan=1 colspan=1>2  8 °C for 24 months</td></tr><tr><td rowspan=1 colspan=1>Freeze &amp; ThawCycle</td><td rowspan=1 colspan=1>Four (4) freeze-thaw cycles whenstored at &quot;10 to &quot;25 °C</td><td rowspan=1 colspan=1>Not available</td></tr><tr><td rowspan=1 colspan=1>Open VialStability</td><td rowspan=1 colspan=1>Not available</td><td rowspan=1 colspan=1>One (1) day when stored at 2-8°C</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

CLSI EP05-A2; Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline, $2 ^ { \mathrm { n d } }$ Edition

CLSI EP6-A; Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach; Approved Guideline

# L. Test Principle:

The VALIDATE® D-Dimer Calibration Verification/Linearity Test Kit is used to verify the calibration of the D-dimer measuring range of the HemosIL® D-Dimer HS assay with IL ACL TOP Family. The kit includes five levels of D-dimer. These five levels of D-Dimer are provided to establish the relationship between theoretical and actual performance of the DDimer analyte quantitatively. The Level 1 D-Dimer is configured to contain the lowest level (lower limit) and Level 5 D-Dimer to contain the highest level (upper limit) of concentration of D-Dimer of the measuring range. The intermediate levels (Level 2, Level 3, and Level 4) are subsequently prepared from Level 1 and Level 5 by equal part dilutions following the CLSI EP6-A guideline to measure intermediate levels of the measuring range. The typical recovery target values for the five levels are:

<table><tr><td rowspan=2 colspan=1>Assay/Analyzer</td><td rowspan=2 colspan=1>Analyte</td><td rowspan=1 colspan=5>Levels (ng/mL DDU)</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>HemosIL D-Dimer HS/ILACL TOP 500</td><td rowspan=1 colspan=1>D-Dimer</td><td rowspan=1 colspan=1>191</td><td rowspan=1 colspan=1>966</td><td rowspan=1 colspan=1>1741</td><td rowspan=1 colspan=1>2515</td><td rowspan=1 colspan=1>3290</td></tr></table>

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility:

The reproducibility study was conducted following the CLSI EP05-A2 guideline. The study was performed utilizing three instruments and three operators testing one lot of VALIDATE D-Dimer across three sites in five replicates per level with one run over 5 days. The study produced a combined total of 75 data points for each level with one lot of HemosIL D-Dimer HS assay on three IL ACL TOP 500 analyzers. The reproducibility study met the pre-specified acceptance criteria. Results from the study are provided in the table below:

<table><tr><td rowspan=1 colspan=9>Instrument: IL ACL TOP 500</td></tr><tr><td rowspan=2 colspan=1>Sample</td><td rowspan=2 colspan=1>N</td><td rowspan=2 colspan=1>Mean(ng/mLDU</td><td rowspan=1 colspan=2>Repeatability</td><td rowspan=1 colspan=2>Within-Laboratory</td><td rowspan=1 colspan=2>Reproducibility</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>Level 1</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>214</td><td rowspan=1 colspan=1>13.6</td><td rowspan=1 colspan=1>6.4</td><td rowspan=1 colspan=1>13.7</td><td rowspan=1 colspan=1>6.4</td><td rowspan=1 colspan=1>15.3</td><td rowspan=1 colspan=1>7.2</td></tr><tr><td rowspan=1 colspan=1>Level 2</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>978</td><td rowspan=1 colspan=1>21.8</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>33.6</td><td rowspan=1 colspan=1>3.4</td><td rowspan=1 colspan=1>40.4</td><td rowspan=1 colspan=1>4.1</td></tr><tr><td rowspan=1 colspan=1>Level 3</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>1722</td><td rowspan=1 colspan=1>50.8</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>97.0</td><td rowspan=1 colspan=1>5.6</td><td rowspan=1 colspan=1>97.0</td><td rowspan=1 colspan=1>5.6</td></tr><tr><td rowspan=1 colspan=1>Level 4</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>2649</td><td rowspan=1 colspan=1>53.9</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>99.2</td><td rowspan=1 colspan=1>3.7</td><td rowspan=1 colspan=1>99.2</td><td rowspan=1 colspan=1>3.7</td></tr><tr><td rowspan=1 colspan=1>Level 5</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>3396</td><td rowspan=1 colspan=1>76.6</td><td rowspan=1 colspan=1>2.3</td><td rowspan=1 colspan=1>124.6</td><td rowspan=1 colspan=1>3.7</td><td rowspan=1 colspan=1>141.9</td><td rowspan=1 colspan=1>4.2</td></tr></table>

# b. Precision/Repeatability:

The repeatability study was conducted testing three lots of VALIDATE D-Dimer at one site on IL ACL TOP 500 with one lot of HemosIL D-Dimer HS assay over 20 days, two runs per day, two replicates per run for Level 1 through Level 5 with a minimum of two operators obtaining a total of 240 replicates for each level. The repeatability study met the pre-determined acceptance criteria. Results from the study are provided in the table below:

<table><tr><td rowspan=1 colspan=13>Instrument: IL ACL TOP 500</td></tr><tr><td rowspan=2 colspan=1>Sample</td><td rowspan=2 colspan=1>N</td><td rowspan=2 colspan=1>Mean(ng/mLDU</td><td rowspan=1 colspan=2>Within-Run</td><td rowspan=1 colspan=2>Between-Run</td><td rowspan=1 colspan=2>Between-day</td><td rowspan=1 colspan=2>Between-Lot</td><td rowspan=1 colspan=2>Total</td></tr><tr><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>Level 1</td><td rowspan=1 colspan=1>240</td><td rowspan=1 colspan=1>204.8</td><td rowspan=1 colspan=1>12.4</td><td rowspan=1 colspan=1>6.0</td><td rowspan=1 colspan=1>4.9</td><td rowspan=1 colspan=1>2.4</td><td rowspan=1 colspan=1>6.4</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>14.8</td><td rowspan=1 colspan=1>7.2</td></tr><tr><td rowspan=1 colspan=1>Level 2</td><td rowspan=1 colspan=1>240</td><td rowspan=1 colspan=1>969.4</td><td rowspan=1 colspan=1>53.4</td><td rowspan=1 colspan=1>5.5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>9.1</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>54.2</td><td rowspan=1 colspan=1>5.6</td></tr><tr><td rowspan=1 colspan=1>Level 3</td><td rowspan=1 colspan=1>240</td><td rowspan=1 colspan=1>1752.3</td><td rowspan=1 colspan=1>55.7</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>25.2</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>41.8</td><td rowspan=1 colspan=1>2.4</td><td rowspan=1 colspan=1>74.1</td><td rowspan=1 colspan=1>4.3</td><td rowspan=1 colspan=1>74.1</td><td rowspan=1 colspan=1>4.3</td></tr><tr><td rowspan=1 colspan=1>Level 4</td><td rowspan=1 colspan=1>239</td><td rowspan=1 colspan=1>2603.2</td><td rowspan=1 colspan=1>101.9</td><td rowspan=1 colspan=1>3.9</td><td rowspan=1 colspan=1>64.1</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>32.6</td><td rowspan=1 colspan=1>1.3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>124.7</td><td rowspan=1 colspan=1>4.8</td></tr><tr><td rowspan=1 colspan=1>Lev5</td><td rowspan=1 colspan=1>240</td><td rowspan=1 colspan=1>3336.2</td><td rowspan=1 colspan=1>105.6</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>58.7</td><td rowspan=1 colspan=1>1.8</td><td rowspan=1 colspan=1>28.5</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>124.1</td><td rowspan=1 colspan=1>3.7</td></tr></table>

C

# c. Linearity/assay reportable range:

Linearity was determined using one lot of the VALIDATE D-Dimer Calibration Verification/Linearity Test kit on the IL ACL TOP 500. The D-dimer concentrations of each measured value of the five levels were plotted vs. five assigned levels of concentration. The results are determined to be linear.

d. Traceability, Stability, Expected values (controls, calibrators, or methods):

Stability Study:

Freeze-Thaw Stability Study: The freeze and thaw vial stability study was carried out by mimicking end user’s usage of the product on three lots of VALIDATE D-Dimer Calibration Verification/Linearity Test kits. The study demonstrated that each level of VALIDATE D-Dimer is stable up to four cycles of freeze and thaw when stored at $\mathrm { \bar { ~ } } 1 0 \mathrm { \circ } _ { \mathrm { C } }$ to $2 5 \mathrm { { } ^ { \circ } C }$ . The study met the pre-determined acceptance criteria.

Closed Vial Stability Study: The closed vial stability study was conducted on three lots of VALIDATE D-Dimer Calibration/Verification Linearity Test Kits at the storage temperature of $\mathrm { \bar { ~ } } 1 0 \mathrm { \textdegree C }$ to $2 5 \mathrm { { } ^ { \circ } C }$ . The study demonstrated that the VALIDATE

D-Dimer Calibration Verification/Linearity Test Kit is stable up to 9 months when stored at $\mathrm { \bar { ~ } } 1 0 \mathrm { \textdegree C }$ to ${ } ^ { - } 2 5 { } ^ { \circ } \mathrm { C }$ . The study met the pre-determined acceptance criteria.

Value Assignment/Recovery Data: The value assignment for the VALIDATE DDimer Calibration Verification/Linearity Test Kit is obtained by testing Level 1 (lowest concentration) and Level 5 (highest concentration) of VALIDATE D-Dimer in six replicates over 5 days to generate 30 replicates on one IL ACL TOP 500. The value assignments for the intermediate levels (Level 2, Level 3 and Level 4) are calculated based on an equal distance (delta) between levels. The value assignment study met the pre-determined acceptance criteria.

d. Detection limit: Not applicable   
e. Analytical specificity: Not applicable   
f. Assay cut-off: Not applicable

2. Comparison studies:

a. Method comparison with predicate device: Not applicable

b. Matrix comparison: Not applicable

3. Clinical studies:

a. Clinical Sensitivity: Not applicable

b. Clinical specificity: Not applicable

4. Clinical cut-off: Not applicable

5. Expected values/Reference range:

The actual expected values will be included in the kit lot Certificate of Analysis sheet for Level 1 and Level 5. The values for mid-levels are calculated based on an equal distance (delta) between levels.

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.